BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28428481)

  • 1. Serum Tartrate-resistant Acid Phosphatase-5b Levels are Associated with the Severity and Extent of Coronary Atherosclerosis in Patients with Coronary Artery Disease.
    Morisawa T; Nakagomi A; Kohashi K; Kusama Y; Shimizu W
    J Atheroscler Thromb; 2017 Oct; 24(10):1058-1068. PubMed ID: 28428481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relationship between coronary and abdominal calcification score, serum osteoprotegerin (OPG), and serum tartrate-resistant acid phosphatase (TRACP) -5b in pre-dialysis CKD patients].
    Shiota J; Izumi N; Kasahara H; Tagawa H; Chiba T; Nihei H
    Nihon Jinzo Gakkai Shi; 2010; 52(8):1022-8. PubMed ID: 21254698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
    Terpos E; de la Fuente J; Szydlo R; Hatjiharissi E; Viniou N; Meletis J; Yataganas X; Goldman JM; Rahemtulla A
    Int J Cancer; 2003 Sep; 106(3):455-7. PubMed ID: 12845688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative immunoassay for tartrate-resistant acid phosphatase isoform 5b using the fluorogenic substrate naphthol ASBI-phosphate and heparin.
    Janckila AJ; Simons RM; Yam LT
    Clin Chim Acta; 2004 Sep; 347(1-2):157-67. PubMed ID: 15313154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tartrate-resistant acid phosphatase 5b is a potential biomarker for rheumatoid arthritis: a pilot study in Han Chinese.
    Cheng T; Wang M; Chen Z; Eisenberg RA; Zhang Y; Zou Y; Deng Y; Wang M; Zhou L
    Chin Med J (Engl); 2014; 127(16):2894-9. PubMed ID: 25131223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease.
    Tousoulis D; Siasos G; Maniatis K; Oikonomou E; Kioufis S; Zaromitidou M; Paraskevopoulos T; Michalea S; Kollia C; Miliou A; Kokkou E; Papavassiliou AG; Stefanadis C
    Int J Cardiol; 2013 Sep; 167(5):1924-8. PubMed ID: 22640692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of serum TRACP in rheumatoid arthritis.
    Janckila AJ; Neustadt DH; Yam LT
    J Bone Miner Res; 2008 Aug; 23(8):1287-95. PubMed ID: 18410226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity.
    Janckila AJ; Takahashi K; Sun SZ; Yam LT
    Clin Chem; 2001 Jan; 47(1):74-80. PubMed ID: 11148180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis.
    Asanuma Y; Chung CP; Oeser A; Solus JF; Avalos I; Gebretsadik T; Shintani A; Raggi P; Sokka T; Pincus T; Stein CM
    Atherosclerosis; 2007 Dec; 195(2):e135-41. PubMed ID: 17570371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoprotegerin is Associated With Endothelial Function and Predicts Early Carotid Atherosclerosis in Patients With Coronary Artery Disease.
    Morisawa T; Nakagomi A; Kohashi K; Kosugi M; Kusama Y; Atarashi H; Shimizu W
    Int Heart J; 2015; 56(6):605-12. PubMed ID: 26549398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum tartrate-resistant acid phosphatase isoforms in rheumatoid arthritis.
    Janckila AJ; Neustadt DH; Nakasato YR; Halleen JM; Hentunen T; Yam LT
    Clin Chim Acta; 2002 Jun; 320(1-2):49-58. PubMed ID: 11983200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive Value of Osteoprotegerin for Detecting Coronary Artery Calcification in Type 2 Diabetes Mellitus Patients in Correlation with Extent of Calcification Detected by Multidetector Computed Tomography.
    Ahmed S; Sobh R
    Endocr Metab Immune Disord Drug Targets; 2019; 19(6):845-851. PubMed ID: 30747085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dried blood spot-based method to measure levels of tartrate-resistant acid phosphatase 5b (TRACP-5b), a marker of bone resorption.
    Eick GN; Devlin MJ; Cepon-Robins TJ; Kowal P; Sugiyama LS; Snodgrass JJ
    Am J Hum Biol; 2019 May; 31(3):e23240. PubMed ID: 30897260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Uric Acid (UA) Negatively Affects Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b) Immunoassay.
    Wu ZQ; Zhang Y; Xie E; Song WJ; Yang RX; Yan CJ; Zhang BF; Xu HG
    PLoS One; 2016; 11(1):e0147554. PubMed ID: 26800211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of immunoassays for serum tartrate-resistant acid phosphatase isoform 5a.
    Chao TY; Lee SH; Chen MM; Neustadt DH; Chaudhry UA; Yam LT; Janckila AJ
    Clin Chim Acta; 2005 Sep; 359(1-2):132-40. PubMed ID: 15993395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased amount of phosphorylated proinflammatory osteopontin in rheumatoid arthritis synovia is associated to decreased tartrate-resistant acid phosphatase 5B/5A ratio.
    Luukkonen J; Pascual LM; Patlaka C; Lång P; Turunen S; Halleen J; Nousiainen T; Valkealahti M; Tuukkanen J; Andersson G; Lehenkari P
    PLoS One; 2017; 12(8):e0182904. PubMed ID: 28792533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker.
    Mori Y; Kasai H; Ose A; Serada M; Ishiguro M; Shiraki M; Tanigawara Y
    Osteoporos Int; 2018 May; 29(5):1155-1163. PubMed ID: 29423715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma osteopontin is correlated with bone resorption markers in rheumatoid arthritis patients.
    Iwadate H; Kobayashi H; Kanno T; Asano T; Saito R; Sato S; Suzuki E; Watanabe H; Ohira H
    Int J Rheum Dis; 2014 Jan; 17(1):50-6. PubMed ID: 24472267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical evaluation of the Nittobo Medical tartrate resistant acid phosphatase isoform 5b (TRACP-5b) EIA and comparison with IDS iSYS in different clinically defined populations.
    Cavalier E; Lukas P; Delanaye P
    Clin Chem Lab Med; 2022 Feb; 60(3):394-400. PubMed ID: 34907694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum osteoprotegerin and its relationship with bone mineral density and markers of bone turnover.
    Indridason OS; Franzson L; Sigurdsson G
    Osteoporos Int; 2005 Apr; 16(4):417-23. PubMed ID: 15776220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.